Strata Critical Medical, Inc.
SRTA
$4.14
-$0.11-2.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.28% | 5.60% | -20.58% | -35.35% | -34.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.28% | 5.60% | -20.58% | -35.35% | -34.80% |
| Cost of Revenue | 33.09% | 6.39% | -18.79% | -36.57% | -35.96% |
| Gross Profit | 38.99% | 2.64% | -27.11% | -30.31% | -29.75% |
| SG&A Expenses | 3.43% | -2.94% | -11.67% | -38.67% | -37.83% |
| Depreciation & Amortization | 107.00% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.91% | 3.28% | -17.03% | -37.62% | -37.13% |
| Operating Income | 40.26% | 12.89% | -12.57% | 51.24% | 49.63% |
| Income Before Tax | -24.16% | 49.40% | 51.98% | 70.17% | 71.91% |
| Income Tax Expenses | 79.76% | 98.46% | 98.26% | 98.74% | 94.27% |
| Earnings from Continuing Operations | -24.16% | 48.19% | 50.82% | 69.23% | 71.18% |
| Earnings from Discontinued Operations | 4,757.10% | 1,661.78% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 251.42% | 178.49% | 61.43% | 46.99% | 51.30% |
| EBIT | 40.26% | 12.89% | -12.57% | 51.24% | 49.63% |
| EBITDA | 63.41% | 10.03% | -23.78% | 58.12% | 55.16% |
| EPS Basic | 242.43% | 170.67% | 63.33% | 49.45% | 53.55% |
| Normalized Basic EPS | 73.25% | -0.09% | -136.48% | 48.19% | 56.18% |
| EPS Diluted | 239.85% | 169.58% | 62.67% | 49.93% | 53.15% |
| Normalized Diluted EPS | 73.25% | -0.09% | -135.47% | 48.27% | 56.23% |
| Average Basic Shares Outstanding | 6.01% | 5.30% | 5.20% | 5.14% | 5.11% |
| Average Diluted Shares Outstanding | 6.01% | 5.30% | 2.86% | 2.77% | 2.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |